Amlodipine/atorvastatin
 | |
 | |
| Combination of | |
|---|---|
| Amlodipine | Calcium channel blocker |
| Atorvastatin | Statin |
| Clinical data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| (verify) | |
The drug combination atorvastatin/amlodipine (trade names Caduet in the US, Australia and Russia, and Envacar elsewhere) is a medication approved by the Food and Drug Administration (FDA) for the treatment of high cholesterol and high blood pressure. It is a fixed-dose combination drug containing the calcium channel blocker amlodipine and the statin atorvastatin being marketed by the pharmaceutical company Pfizer.[1]
References
- ^ "CADUET (amlodipine besylate/atorvastatin calcium) Tablets" (PDF). NDA 21-540/S-009. United States Food and Drug Administration. February 2010. Retrieved 2010-09-25.
External links
- Manufacturer's site (caduet.com)
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |